Hologic Stock Plummets to 4th Consecutive Day of Decline with $212 Million Trading Volume

On May 5, 2025, Hologic (HOLX) experienced a significant decline, with its trading volume reaching $212 million, marking a 49.31% decrease from the previous day. The stock closed down 2.64%, marking its fourth consecutive day of decline, with a total drop of 9.65% over the past four days.
Hologic reported strong earnings and revenue for the second quarter of fiscal 2025, but the company lowered its earnings per share (EPS) outlook for the year. The earnings beat was primarily driven by an unexpected $10 million and $0.01 earnings surplus. However, the company's revenue guidance for the next quarter fell short of Wall Street's estimates, and its EPS guidance for the next quarter also missed expectations.
Following the release of its second-quarter financial results, Hologic's stock price target was reduced from $75 to $65 by Mizuho. The diagnostic product maker's shares plunged in early premarket trading after it lowered its guidance due to tariffs and geopolitical issues. The company's EPS for the second quarter missed expectations, which contributed to the stock's decline.
Comments
No comments yet